Expression of Cancer‐Testis Antigens MAGE‐A1, MAGE‐A4, NY‐ESO‐1 and PRAME in Bone and Soft Tissue Sarcomas: The Experience From a Single Center in China
ABSTRACT Objective Sarcomas are a heterogeneous group of malignancies, low disease‐control levels and the limited durability of responses have prompted the exploration of various novel immunotherapeutic approaches. To preliminarily explore the feasibility of cancer vaccines based on cancer testis an...
Saved in:
| Main Authors: | Anni Chen, Yuling Qiu, Ying‐Tzu Yen, Chun Wang, Xiaolu Wang, Chunhua Li, Zijian Wei, Lin Li, Lixia Yu, Fangcen Liu, Rutian Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70750 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
by: A. A. Solodovnik, et al.
Published: (2018-07-01) -
Mechanism of action of over-expressing NY-ESO-1 in vesicular stomatitis virus and its combination therapy with NY-ESO-1 TCR-T
by: Ting Tian, et al.
Published: (2025-08-01) -
Cancer-testis antigen MAGE-C1/ CT7 in multiple myeloma: literature review
by: E. A. Makunina
Published: (2020-12-01) -
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system
by: Xiaojing Tina Chen, et al.
Published: (2024-12-01) -
<i>MAGE-C1</i> gene and mage-c1 protein expression comparison in primary multiple myeloma patients
by: E. A. Makunina, et al.
Published: (2022-04-01)